DICYCLOMINE 20 MG TABLET
For 30 tablets
Pharmacies pay
$1.77 filed
30 × $0.059 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$4.98 filed
30 × $0.166 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
2.8× estimated
Medicare paid 2.8× what pharmacies pay.
Part D averages every strength and form sold under “Dicyclomine HCl*” / “Dicyclomine HCl” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$7.04 estimated
$1.77 + $0.27 (15%) + $5.00 fee per fill = $7.04
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
DICYCLOMINE 20 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as dicyclomine hydrochloride, under the trade name “Dicyclomine”.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 13 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Lannett Company, LLC and Actavis Pharma, Inc.
FDA’s Established Pharmacologic Class for it is Anticholinergic.
The NADAC file of 2026-10-14 prices it under 24 NDCs (National Drug Codes); the FDA directory lists 23 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $1.77 for 30 tablets (30 × $0.059 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 13 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Actavis Pharma, Inc. | 2 | $0.059 per EA filed |
| Advagen Pharma Ltd., | 2 | $0.059 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.059 per EA filed |
| Bionpharma Inc. | 2 | $0.059 per EA filed |
| Camber Pharmaceuticals, Inc. | 2 | $0.059 per EA filed |
| Hikma Pharmaceuticals USA Inc. | 2 | $0.059 per EA filed |
| Lannett Company, LLC | 2 | $0.059 per EA filed |
| Rising Pharma Holdings, Inc. | 2 | $0.059 per EA filed |
| Solaris Pharma Corporation | 2 | $0.059 per EA filed |
| Upsher-Smith Laboratories, LLC | 2 | $0.059 per EA filed |
| American Health Packaging | 1 | $0.059 per EA filed |
| Chartwell RX, LLC | 1 | $0.059 per EA filed |
| Major Pharmaceuticals | 1 | $0.059 per EA filed |
| Not listed as a package in the FDA directory | 1 | $0.059 per EA filed |
All 24 NDCs, with labeler and price
- 00143-1227-01 · Hikma Pharmaceuticals USA Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 00143-1227-10 · Hikma Pharmaceuticals USA Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 00527-1282-01 · Lannett Company, LLC · $0.059 per EA · eff. 2026-09-23 filed
- 00527-1282-10 · Lannett Company, LLC · $0.059 per EA · eff. 2026-09-23 filed
- 00591-0795-01 · Actavis Pharma, Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 00591-0795-10 · Actavis Pharma, Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 00904-6988-61 · Major Pharmaceuticals · $0.059 per EA · eff. 2026-09-23 filed
- 16571-0259-01 · Rising Pharma Holdings, Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 16571-0259-10 · Rising Pharma Holdings, Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 24979-0200-01 · Upsher-Smith Laboratories, LLC · $0.059 per EA · eff. 2026-09-23 filed
- 24979-0200-03 · Upsher-Smith Laboratories, LLC · $0.059 per EA · eff. 2026-09-23 filed
- 31722-0079-01 · Camber Pharmaceuticals, Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 31722-0079-10 · Camber Pharmaceuticals, Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 59651-0720-01 · Aurobindo Pharma Limited · $0.059 per EA · eff. 2026-09-23 filed
- 59651-0720-99 · Aurobindo Pharma Limited · $0.059 per EA · eff. 2026-09-23 filed
- 60687-0380-01 · American Health Packaging · $0.059 per EA · eff. 2026-09-23 filed
- 60687-0380-11 · not listed as a package in the FDA directory · $0.059 per EA · eff. 2026-09-23 filed
- 62135-0428-12 · Chartwell RX, LLC · $0.059 per EA · eff. 2026-09-23 filed
- 69452-0311-20 · Bionpharma Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 69452-0311-32 · Bionpharma Inc. · $0.059 per EA · eff. 2026-09-23 filed
- 72888-0119-00 · Advagen Pharma Ltd., · $0.059 per EA · eff. 2026-09-23 filed
- 72888-0119-01 · Advagen Pharma Ltd., · $0.059 per EA · eff. 2026-09-23 filed
- 73473-0902-01 · Solaris Pharma Corporation · $0.059 per EA · eff. 2026-09-23 filed
- 73473-0902-10 · Solaris Pharma Corporation · $0.059 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
2 other products in the NADAC file share the FDA nonproprietary name dicyclomine hydrochloride with DICYCLOMINE 20 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| DICYCLOMINE 10 MG CAPSULE | $0.07775 per EA filed | $0.166 per EA filed |
| DICYCLOMINE 10 MG/5 ML SOLN | $0.17356 per ML filed | We don’t know yet |
| DICYCLOMINE 20 MG TABLET this page | $0.059 per EA filed | $0.166 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 24 NDCs’ NADAC prices is $0.059 per EA filed.
Of the 23 other products in FDA’s Anticholinergic class priced per EA, 23 have a higher middle NADAC price and 0 a lower one. The one in the middle is SCOPOLAMINE 1 MG/3 DAY PATCH, at $4.33565 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $4.98 for 30 tablets, at an average of $0.166 per EA in 2024 (2024-01-01 to 2024-12-31) for “Dicyclomine HCl*” and “Dicyclomine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 2,350,747 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for DICYCLOMINE 20 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Dicyclomine HCl* / Dicyclomine HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name. *: CMS says this average reflects multiple routes of administration, which may have different unit prices. All 51 NADAC NDCs the name join matched to it have an FDA route including ORAL. 3 of the 48 NDCs that point at this name are not listed in the FDA NDC Directory as packages of their own; their route was taken from FDA's record for the same product (labeler and product code). 48 of 51 NADAC NDCs joined to this name are priced per EA (3 per ML): CMS's average mixes those units.
Related pages
Its pharmacologic class
Related in the same class
- TRELEGY ELLIPTA 100-62.5-25
- IPRATROPIUM BR 0.02% SOLN
- BENZTROPINE MES 0.5 MG TAB
- BREZTRI AEROSPHERE 160-9-4.8 MCG
- ANORO ELLIPTA 62.5-25 MCG INH